ERBB2 and neoplasm: On the other hand, Xu et al. (2018) and Arias-Pulido et al. (2018) reported that high CD20+ cell count was a favourable prognostic factor (p = 0.004 and p = 0.005 respectively) independent of tumour stage, histological grade, hormone receptors status and HER2 status [33,34].